Literature DB >> 12867382

Myopic choroidal neovascularization: a 10-year follow-up.

Takeshi Yoshida1, Kyoko Ohno-Matsui, Kenjiro Yasuzumi, Ariko Kojima, Noriaki Shimada, Soh Futagami, Takashi Tokoro, Manabu Mochizuki.   

Abstract

PURPOSE: To clarify the long-term visual outcome of choroidal neovascularization (CNV) in eyes with high myopia in Asian patients.
DESIGN: We reviewed the medical records of 25 consecutive patients (27 eyes) with myopic CNV who were followed up for at least 10 years after the onset of CNV. Visual acuity was examined 10 years after CNV onset. INTERVENTION: Demographic and clinical data were obtained from the patients' medical records. MAIN OUTCOME MEASURES: Visual acuity readings during the 10 years after CNV onset.
RESULTS: At the onset of CNV, 19 eyes (70.4%) had a visual acuity better than 20/200, and six eyes (22.2%) had a visual acuity better than 20/40. Three years after the onset of CNV, 15 eyes (55.5%) retained a visual acuity of better than 20/200. At 5 and 10 years after the onset, however, visual acuity dropped to 20/200 or less in 24 eyes (88.9%) and in 26 eyes (96.3%), respectively. The logarithm of the minimum angle of resolution (logMAR) visual acuity was significantly worse at 5 and 10 years after onset as compared with that at CNV onset. Chorioretinal atrophy developed around the regressed CNV in 26 eyes (96.3%) at 5 and 10 years after the onset of CNV.
CONCLUSIONS: Long-term visual outcome of myopic CNV is extremely poor. The visual acuity of almost all of the patients dropped to 20/200 or less within 5 to 10 years after the onset of CNV, secondary to the development of chorioretinal atrophy around the regressed CNV. These findings indicate that active treatments should be recommended to prevent long-term visual impairment in Asian patients with myopic CNV.

Entities:  

Mesh:

Year:  2003        PMID: 12867382     DOI: 10.1016/S0161-6420(03)00461-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  76 in total

1.  Visual outcomes for high myopic patients with or without myopic maculopathy: a 10 year follow up study.

Authors:  Y-F Shih; T-C Ho; C K Hsiao; L L-K Lin
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization.

Authors:  U Introini; G Casalino; G Querques; A T Gimeno; F Scotti; F Bandello
Journal:  Eye (Lond)       Date:  2012-04-27       Impact factor: 3.775

3.  Factors associated with enlargement of chorioretinal atrophy after intravitreal bevacizumab for myopic choroidal neovascularization.

Authors:  Riyo Uemoto; Houmei Nakasato-Sonn; Tatsukata Kawagoe; Meguro Akira; Eiichi Okada; Nobuhisa Mizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-22       Impact factor: 3.117

Review 4.  Choroidal neovascularisation in pathological myopia: an update in management.

Authors:  W-M Chan; M Ohji; T Y Y Lai; D T L Liu; Y Tano; D S C Lam
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

5.  Choroidal neovascularization in highly myopic eyes after cataract surgery.

Authors:  Kengo Hayashi; Kyoko Ohno-Matsui; Soh Futagami; Seiji Ohno; Takashi Tokoro; Manabu Mochizuki
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

6.  Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.

Authors:  P J Rosenfeld
Journal:  Br J Ophthalmol       Date:  2007-02       Impact factor: 4.638

7.  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Amy L Wong; David T L Liu; Dennis S C Lam
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

8.  Transpupillary thermotherapy for myopic choroidal neovascularization: 1-year follow-up: TTT for myopic CNV.

Authors:  Sengul Ozdek; Ahmet Hondur; Gokhan Gurelik; Berati Hasanreisoglu
Journal:  Int Ophthalmol       Date:  2006-11-16       Impact factor: 2.031

9.  Estimation of visual outcome without treatment in patients with subfoveal choroidal neovascularization in pathologic myopia.

Authors:  Ariko Kojima; Kyoko Ohno-Matsui; Satoshi Teramukai; Yoko Ishihara; Noriaki Shimada; Takeshi Yoshida; Yoshiharu Sugamoto; Takashi Tokoro; Manabu Mochizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-21       Impact factor: 3.117

10.  Intravitreal bevacizumab on myopic choroidal neovascularization that was refractory to or had recurred after photodynamic therapy.

Authors:  Kengo Hayashi; Kyoko Ohno-Matsui; Noriaki Shimada; Muka Moriyama; Wakako Hara; Takeshi Yoshida; Takashi Tokoro; Manabu Mochizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-16       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.